13:09 EDT Capricor Therapeutics (CAPR) trading halted, volatility trading pause
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPR:
- Capricor Therapeutics announces four-year data from HOPE-2 OLE study
- FDA’s Nicole Verdun placed on administrative leave, STAT reports
- Capricor Therapeutics announces ODD to Deramiocel
- Capricor treatment of Becker muscular dystrophy granted orphan designation
- Roth thinks Capricor Therapeutics drug could still be approved by August 31